CCI
Columbus Circle Investors Portfolio holdings
AUM
$2.28B
1-Year Return
135.58%
This Quarter Return
+3.29%
1 Year Return
+135.58%
3 Year Return
+366.07%
5 Year Return
+793.68%
10 Year Return
–
AUM
$7.66B
AUM Growth
-$1.58B
(-17%)
Cap. Flow
-$1.41B
Cap. Flow
% of AUM
-18.41%
Top 10 Holdings %
Top 10 Hldgs %
21.79%
Holding
333
New
65
Increased
66
Reduced
120
Closed
78
Top Buys
| 1 |
Caterpillar
CAT
|
+$108M |
| 2 |
Netflix
NFLX
|
+$74.7M |
| 3 |
Booking.com
BKNG
|
+$70.6M |
| 4 |
Diamondback Energy
FANG
|
+$70.4M |
| 5 |
CME Group
CME
|
+$65.9M |
Top Sells
| 1 |
PPG Industries
PPG
|
+$137M |
| 2 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$135M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$120M |
| 4 |
Constellation Brands
STZ
|
+$117M |
| 5 |
Meta Platforms (Facebook)
META
|
+$101M |
Sector Composition
| 1 | Technology | 22.42% |
| 2 | Consumer Discretionary | 17.4% |
| 3 | Healthcare | 15.46% |
| 4 | Industrials | 12.21% |
| 5 | Financials | 9.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Ocular Therapeutix
OCUL
$2.24B
| $3.94M | 0.05% |
470,090
-21,114
| -4% | -$177K |
|
202
Acadia Pharmaceuticals
ACAD
$4.19B
| $3.68M | 0.05% |
+127,533
| New | +$3.68M |
|
203
TG Therapeutics
TGTX
$5.04B
| $3.61M | 0.05% |
776,699
+141,339
| +22% | +$657K |
|
|
HEES
204
DELISTED
H&E Equipment Services
HEES
| $3.27M | 0.04% |
+140,833
| New | +$3.27M |
|
205
TherapeuticsMD
TXMD
$12.6M
| $3.05M | 0.04% |
10,567
+7,935
| +301% | +$2.29M |
|
206
Novartis
NVS
$248B
| $3.03M | 0.04% |
46,478
-99,231
| -68% | -$6.48M |
|
207
Eli Lilly
LLY
$674B
| $2.82M | 0.04% |
38,306
-1,295,516
| -97% | -$95.3M |
|
208
Amgen
AMGN
$152B
| $2.78M | 0.04% |
+19,032
| New | +$2.78M |
|
209
Henry Schein
HSIC
$8.16B
| $2.6M | 0.03% |
43,656
-82,197
| -65% | -$4.89M |
|
|
BCR
210
DELISTED
CR Bard Inc.
BCR
| $2.17M | 0.03% |
+9,648
| New | +$2.17M |
|
211
Charles River Laboratories
CRL
$7.76B
| $2.14M | 0.03% |
28,021
-79,645
| -74% | -$6.07M |
|
212
Universal Health Services
UHS
$11.8B
| $2.09M | 0.03% |
19,669
-16,003
| -45% | -$1.7M |
|
213
AtriCure
ATRC
$1.79B
| $2.04M | 0.03% |
104,179
-59,538
| -36% | -$1.17M |
|
|
INXN
214
DELISTED
Interxion Holding N.V.
INXN
| $2M | 0.03% |
57,095
+29,874
| +110% | +$1.05M |
|
215
Vertex Pharmaceuticals
VRTX
$102B
| $1.86M | 0.02% |
25,186
-51,013
| -67% | -$3.76M |
|
|
ICD
216
DELISTED
Independence Contract Drilling, Inc.
ICD
| $1.76M | 0.02% |
+13,145
| New | +$1.76M |
|
217
Monolithic Power Systems
MPWR
$40.7B
| $1.59M | 0.02% |
19,350
+5,524
| +40% | +$452K |
|
218
Stryker
SYK
$150B
| $1.53M | 0.02% |
12,747
-17,447
| -58% | -$2.09M |
|
219
MasTec
MTZ
$13.8B
| $1.52M | 0.02% |
+39,650
| New | +$1.52M |
|
220
Supernus Pharmaceuticals
SUPN
$2.56B
| $1.41M | 0.02% |
+55,973
| New | +$1.41M |
|
221
Boston Scientific
BSX
$161B
| $1.41M | 0.02% |
65,272
-3,961,445
| -98% | -$85.7M |
|
222
Humana
HUM
$36.9B
| $1.41M | 0.02% |
6,901
-13,791
| -67% | -$2.81M |
|
|
AET
223
DELISTED
Aetna Inc
AET
| $1.4M | 0.02% |
+11,296
| New | +$1.4M |
|
|
LUMO
224
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $1.38M | 0.02% |
14,914
+2,804
| +23% | +$259K |
|
225
Vanda Pharmaceuticals
VNDA
$266M
| $1.36M | 0.02% |
85,307
+1,196
| +1% | +$19.1K |
|